Biblio

2019
Lu N, Lu Y, Liu S, Jin C, Fang S, Zhou X, Li Z. Tailor-Engineered POSS-based Hybrid Gels for Bone Regeneration. Biomacromolecules. 2019.
Sin-Chan P, Mumal I, Huang A. Tails of a Super Histone. Cancer Cell. 2019;35(1):7-9.
Stratton JAnne, Shah P, Sinha S, Crowther E, Biernaskie J. A tale of two cousins: Ependymal cells, quiescent neural stem cells and potential mechanisms driving their functional divergence. FEBS J. 2019.
Hu B. A tale of two eras: the story of autologous stem cell transplantation with and without thiotepa for primary central nervous system lymphoma. Biol Blood Marrow Transplant. 2019.
Gagelmann N, Eikema D-J, Koster L, Caillot D, Pioltelli P, Lleonart JBargay, Reményi P, Blaise D, Schaap N, Trneny M, et al. Tandem autologous stem cell transplantation improves outcome in newly diagnosed multiple myeloma with extramedullary disease and high-risk cytogenetics: a study from the Chronic Malignancies Working Party of EBMT. Biol Blood Marrow Transplant. 2019.
Giralt S, Costa LJ, Maloney D, Krishnan A, Fei M, Antin JH, Brunstein C, Geller N, Goodman S, Hari P, et al. Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Multiple Myeloma: Long-term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0102 Trial. Biol Blood Marrow Transplant. 2019.
Choi JYoon, Kang HJin, Hong KTaek, Hong CRy, Lee YJeong, Park JDong, Phi JHoon, Kim S-K, Wang K-C, Kim IHan, et al. Tandem high-dose chemotherapy with topotecan-thiotepa-carboplatin and melphalan-etoposide-carboplatin regimens for pediatric high-risk brain tumors. Int J Clin Oncol. 2019.
Freeman AF, Yazigi N, Shah NN, Kleiner DE, Parta M, Atkinson P, Heller T, Holland SM, Kaufman SS, Khan KM, et al. Tandem Orthotopic Living Donor Liver Transplantation Followed by Same Donor Haploidentical Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency: Tandem Liver and Bone Marrow Transplant in DOCK8 Deficiency. Transplantation. 2019.
Nasiri N, Hosseini S, Alini M, Khademhosseini A, Eslaminejad MBaghaban. Targeted Cell Delivery for Articular Cartilage Regeneration and Osteoarthritis Treatment. Drug Discov Today. 2019.
Liao Y, Ma Z, Zhang Y, Li D, Lv D, Chen Z, Li P, Ai-Dherasi A, Zheng F, Tian J, et al. Targeted deep sequencing from multiple sources demonstrates increased NOTCH1 alterations in lung cancer patient plasma. Cancer Med. 2019.
Bai M, Han Y, Wu Y, Liao J, Li L, Wang L, Li Q, Xing W, Chen L, Zou W, et al. Targeted genetic screening in mice through haploid embryonic stem cells identifies critical genes in bone development. PLoS Biol. 2019;17(7):e3000350.
Chheda JJ, Tarleton A, Eidem JH. Targeted Prophylaxis With Voriconazole in Heart Transplant Patients: A Focus on the Interaction With Tacrolimus. J Pharm Technol. 2019;35(4):164-171.
Hwang SMee, Kim S-M, Nam Y, Kim J, Kim S, Ahn Y-O, Park Y, Yoon S-S, Shin S, Kwon S, et al. Targeted sequencing aids in identifying clonality in chronic myelomonocytic leukemia. Leuk Res. 2019;84:106190.
Mathot F, Shin AY, van Wijnen AJ. Targeted stimulation of MSCs in peripheral nerve repair. Gene. 2019.
McCarthy SDS, Leontyev D, Nicoletti P, Binnington B, Kozlowski HN, Ostrowski M, Cochrane A, Branch DR, Wong RW. Targeting ABL1 or ARG Tyrosine Kinases to Restrict HIV-1 Infection in Primary CD4+ T-Cells or in Humanized NSG Mice. J Acquir Immune Defic Syndr. 2019;82(4):407-415.
Bort A, Sánchez BG, Mateos-Gómez PA, Vara-Ciruelos D, Rodríguez-Henche N, Díaz-Laviada I. Targeting AMP-activated kinase impacts hepatocellular cancer stem cells induced by long-term treatment with sorafenib. Mol Oncol. 2019.
Xu Q, Long Q, Zhu D, Fu D, Zhang B, Han L, Qian M, Guo J, Xu J, Cao L, et al. Targeting amphiregulin (AREG) derived from senescent stromal cells diminishes cancer resistance and averts programmed cell death 1 ligand (PD-L1)-mediated immunosuppression. Aging Cell. 2019:e13027.
Nalivaeva NN, Turner AJ. Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy. Br J Pharmacol. 2019.
Lima-Fernandes E, Murison A, Medina Tda Silva, Wang Y, Ma A, Leung C, Luciani GM, Haynes J, Pollett A, Zeller C, et al. Targeting bivalency de-represses Indian Hedgehog and inhibits self-renewal of colorectal cancer-initiating cells. Nat Commun. 2019;10(1):1436.
Parizadeh SMostafa, Jafarzadeh-Esfehani R, Hassanian SMahdi, Parizadeh SMohammad R, Vojdani S, Ghandehari M, Ghazaghi A, Khazaei M, ShahidSales S, Rezayi M, et al. Targeting cancer stem cells as therapeutic approach in the treatment of colorectal cancer. Int J Biochem Cell Biol. 2019.
Dwivedi ARanjan, Thakur A, Kumar V, Skvortsova I, Kumar V. Targeting Cancer Stem Cells Pathways for the Effective Treatment of Cancer. Curr Drug Targets. 2019.
Ngoi NYL, Eu JQing, Hirpara J, Wang L, Lim JSJ, Lee S-C, Lim Y-C, Pervaiz S, Goh BCher, Wong ALA. Targeting Cell Metabolism as Cancer Therapy. Antioxid Redox Signal. 2019.
Zhang X, Cai D, Zhou F, Yu J, Wu X, Yu D, Zou Y, Hong Y, Yuan C, Chen Y, et al. Targeting downstream subcellular YAP activity as a function of matrix stiffness with Verteporfin-encapsulated chitosan microsphere attenuates osteoarthritis. Biomaterials. 2019;232:119724.
Kitson SJ, Rosser M, Fischer DP, Marshall KM, Clarke RB, Crosbie EJ. Targeting Endometrial Cancer Stem Cell Activity with Metformin Is Inhibited by Patient-Derived Adipocyte-Secreted Factors. Cancers (Basel). 2019;11(5).
Hetzler PTheodore, Dash BC, Guo S, Hsia HC. Targeting Fibrotic Signaling: A Review of Current Literature and Identification of Future Therapeutic Targets to Improve Wound Healing. Ann Plast Surg. 2019.

Pages